Bringing extensive experience in venture capital, the fund manager has successfully engaged in over 30 investments primarily in the life sciences and technology sectors across Europe and North America. With a strong emphasis on early-stage opportunities, the manager adopts a data-driven approach, fostering innovation in healthcare and biotech. Noteworthy exits include several high-impact companies, demonstrating a commitment to scaling operations and maximizing strategic growth. Their operator-first style emphasizes collaboration with portfolio companies, ensuring alignment with market needs and enhancing value creation.